News

3Q16 Earnings Release

São Paulo, November 9, 2016 - Alliar - Centro de Imagem Diagnósticos S.A. hereby announces its 3Q16 results.

  • Net Revenue of R$253.7 million, up by 37.1% (+17.1% pro forma)
  • Adjusted EBITDA of R$59.4 million, an increase of 45.7% (+27,3% pro forma) and Adjusted LTM EBITDA of R$200.6 million (share traded at EV/EBITDA of 11.1x )
  • Adjusted pro forma EBITDA Margin of 23.4% (pro forma improvement of 188 bps)
  • Recurring Net Income of R$14.1 million, versus a net loss of R$30.9 million in 3Q15
  • LTM ROIC ex goodwill of 20.1%
  • Installation of 2 new MRI machines (total of 114) and 9 new clinical analysis (CA) collection rooms (total of 183)
  • Ongoing construction works in 7 new PSCs (3 mega and 4 collection points), led by the Ana Rosa and Morumbi mega PSCs in São Paulo (SP) (the first of which began operations on October 15) and the Bernardo Monteiro mega PSC in Belo Horizonte (MG).
  • 4 target-companies undergoing due diligence
  • 13 new medical partners, strengthening Alliar’s medical partnership model
  • Conclusion of the integration of Delfin Imagem, acquired in March 2016

Click here to access the Earnings Release.

Conference Call in English

Conference Call in Portuguese

November 10, 2016
12:30 p.m. (Local time)
9:30 a.m. (NY time)
Phone: +1 (516) 300-1066
Phone: +55 (11) 3127-4971
Code: Alliar
Webcast: click here

Replay: available until 11/17
Phone: +55 (11) 3127 4999
(Code: 75227915)

November 10, 2016
1:30 p.m. (Local time)
10:30 a.m. (NY time)
Phone: +55 (11) 3127-4971
Code: Alliar
Webcast: click here

Replay: available until 17/11
Phone: +55 (11) 3127 4999
(Code: 72338311)

IR Contact

Carlos Thiago de Souza Araujo
Investor Relations Officer
Email: ri@alliar.com